Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PY7Z
|
|||
| Former ID |
DNCL003179
|
|||
| Drug Name |
Aflunov
|
|||
| Synonyms |
Aflunov (TN)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza A virus H5N1 infection [ICD-11: 1E30] | Phase 1/2 | [1] | |
| Company |
Novartis Vaccines & Diagnostics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00814385) Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04. U.S. National Institutes of Health. | |||
| REF 2 | Aflunov( ): a prepandemic influenza vaccine. Expert Rev Vaccines. 2012 Feb;11(2):145-57. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.